바로가기메뉴

본문 바로가기 주메뉴 바로가기

Association Analysis of MUC5AC Promoter Polymorphism with Asthma

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2007, v.63 no.3, pp.235-241






  • Downloaded
  • Viewed

Abstract

Background: Airway mucus hypersecretion plays an important role in the pathogenesis of asthma, and is associated with the induction of MUC5AC expression in airway secretion. The MUC5AC gene is highly polymorphic; however, there are few studies about the association between the polymorphisms of the MUC5AC gene and asthma susceptibility or asthma phenotypes. We have investigated the association of MUC5AC promoter polymorphisms with the risk of asthma and asthma phenotypes. Methods: We determined the genotypes of the MUC5AC promoter (-1274G>A) in 78 asthma patients and in 78 age, sex-matched control individuals in the Korean population. Genomic DNAs from blood were analyzed by PCR and RFLP (restriction fragment length polymorphism) determination. We examined FEV1, total eosinophil count, serum IgE level, PC20 and the presence of atopy (by a skin test) in asthma patients. Results: The mean age of the patients was 47.7 ± 16.1 years and 38.5% were men, and the mean FEV1 was 84.4 ± 22.3% of predicted in the asthma patients. The -1274G>A polymorphism of the MUC5AC promoter in asthma patients was not significantly different as compared with normal individuals (GG 57.7%, AG 34.6% and AA 7.7% in asthma patients vs. GG 56.4%, AG 38.5% and AA 5.1% in control subject, p = 0.752, Cod). Several clinical parameters in asthma patients such as FEV1, total eosinophil count, serum IgE level, PC20 and the presence of atopy, were not associated with the -1274G>A polymorphism of the MUC5AC promoter. Conclusion: The -1274G>A single nucleotide polymorphism (SNP) frequency of the MUC5AC promoter was not associated with asthma in a Korean population. (Tuberc Respir Dis 2007; 63: 235-241)

keywords
Asthma, MUC5AC, Single nucleotide polymorphism., Asthma, MUC5AC, Single nucleotide polymorphism.

Reference

1.

(2006) Global Strategy for Asthma Management and Prevention, M.D: National Heart, Lung and Blood Institute

2.

(2006) Mucus and MUC in asthma,

3.

(2006) Respiratory tract mucin genes and mucin glycoproteins in health and disease,

4.

(2002) Goblet cell and mucin gene abnormalities in asthma,

5.

(2000) Polymorphism of human mucin genes in chest disease: possible significance of MUC2,

6.

(1996) MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions,

7.

(2005) Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants,

8.

(2001) Genetic polymorphism of MUC7: allele frequencies and association with asthma,

9.

(1998) Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism,

10.

(1998) Cloning of the amino-terminal and 5’-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts,

11.

(2006) Dexamethasone-mediated repression of MUC5AC gene expression in human lung epithelial cells,

12.

(2005) Promoter analysis and aberrant expression of the MUC5B gene in diffuse panbronchiolitis,

13.

(2006) Regulation of mucin genes in chronic inflammatory airway diseases,

14.

(2001) Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression,

15.

(2004) Airway mucus hypersecretion in asthma: an undervalued pathology? ,

16.

(2006) Airway mucus: from production to secretion,

17.

Cloning and analysis of cDNA encoding a major airway glycoprotein,

18.

(2006) Mucin genes have different expression patterns in healthy and diseased upper airway mucosa,

Tuberculosis & Respiratory Diseases